Ann: NEW 2022 Annual General Meeting Date, page-30

I agree with you on this. Their track record with Biotech has been pretty impressive. At the end of the day we need a good salesman (salesgroup). and a kick ass marketing campaign.
If they can achieve what they've already done with other penny stock biotechs then I know where my votes going as a punt. It also is quite interesting how after many of this forums members asking for updates, action etc etc with no viable responses for the past 5 years or so, when a genuine threat to their BOD's salaries surfaces, we have one of the most passionate and thorough responses addressed to the shareholders that we've EVER had.
There was a small group of us a few years ago that were trying to do the same thing but we only managed to get just over 2.5% of the total company.
I think a shake up is needed.
Just my opinion though. Good luck to all of you and best wishes to those suffering from PD and Diabietes.
Dave.